59 / 100

Dr. Xiang Yu, Controlled Release, Best Researcher Award

Doctorate at Huzhou Central Hospital, China


Dr. Xiang Yu is a pharmaceutical scientist specializing in the development of advanced drug delivery systems aimed at countering the adverse effects of ionizing radiation. He earned his Ph.D. in Pharmaceutical Sciences from Shenyang Pharmaceutical University in 2020. Since then, he has been contributing to cutting-edge research at the Clinical Trial Center of Huzhou Central Hospital, affiliated with Zhejiang University School of Medicine. Dr. Yu’s innovative work in anti-radiation therapy earned him the prestigious “Leading Medical Talents in South Taihu Lake” award in 2021. His dedication to improving therapeutic approaches reflects his commitment to advancing medical science and enhancing patient care.

Professional Profile:


Ph.D. in Pharmaceutical Sciences

  • Shenyang Pharmaceutical University, 2016-2020

Professional Experience:

Dr. Xiang Yu is currently working at the Clinical Trial Center at Huzhou Central Hospital, which is affiliated with Huzhou Hospital and Zhejiang University School of Medicine in Huzhou. Since joining the institution in 2020, Dr. Yu has been deeply involved in clinical trials focusing on the development of innovative anti-radiation drug delivery systems. His role involves designing, conducting, and analyzing clinical studies aimed at assessing the efficacy and safety of these advanced therapies. His work is pivotal in translating novel pharmaceutical innovations from the lab to clinical settings, ensuring they meet the highest standards of medical care and efficacy.

Research Interest:

Dr. Xiang Yu’s research interests lie in the in-depth exploration of innovative anti-radiation drug delivery systems. He focuses on their design and efficacy in mitigating the detrimental effects of ionizing radiation, aiming to develop more effective treatments to protect patients from radiation-related damage.

Awards and Honors:

  • Leading Medical Talents in South Taihu Lake, 2021

Top Noted Publication:

Estriol Dissolving Microneedle Patches for Protection Against Ionizing Radiation-Induced Injury

  • Authors: Zhu, L., Yu, X., Li, Q., Jin, Y., Du, L.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2021
  • Volume: 163
  • Article Number: 105881
  • Citations: 4

Facile Preparation of Solid Dispersions by Dissolving Drugs in N-vinyl-2-pyrrolidone and Photopolymerization

  • Authors: Fang, R., Liu, Y., Ma, L., Yu, X., Jin, Y.
  • Journal: Materials Science and Engineering C
  • Year: 2021
  • Volume: 124
  • Article Number: 112063
  • Citations: 5

Minimally Invasive Dissolving Microneedles for Ocular Brinzolamide Delivery

  • Authors: Li, M.-S., Yu, X., Jin, Y.-G., Wu, Z.-H.
  • Journal: Yaoxue Xuebao
  • Year: 2021
  • Volume: 56
  • Issue: 3
  • Pages: 849–854
  • Citations: 3

Inhalable Jojoba Oil Dry Nanoemulsion Powders for the Treatment of Lipopolysaccharide- or H2O2-Induced Acute Lung Injury

  • Authors: Zhang, G., Xie, F., Sun, Y., Du, L., Jin, Y.
  • Journal: Pharmaceutics
  • Year: 2021
  • Volume: 13
  • Issue: 4
  • Article Number: 486
  • Citations: 17

Ocular Lamellar Crystalline Gels for Sustained Release and Enhanced Permeation of Resveratrol Against Corneal Neovascularization

  • Authors: Li, M., Yu, X., Zhu, L., Jin, Y., Wu, Z.
  • Journal: Drug Delivery
  • Year: 2021
  • Volume: 28
  • Issue: 1
  • Pages: 206–217
  • Citations: 8
Xiang Yu | Controlled Release | Best Researcher Award

You May Also Like